Stivarga
regorafenib
Listed by Bayer HealthCare Pharmaceuticals Inc.
- Strength
- 40 mg/1
- Form
- Tablet, Film Coated
- Route
- Oral
- Class
- Kinase Inhibitor
What it contains
- Regorafenib 40 mg/1
FDA record
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Kinase Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 50419-171 |
| FDA application | NDA203085 |
| RxNorm concept | 1312402 |
| Package sizes listed | 4 |
| Marketed since | September 2012 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.